Manni Kantipudi joined Aragen (formerly known as GVK BIO) in 2007 as President. He is presently CEO and member of the Board of Directors, responsible for the overall growth, strategy, M&A and culture of the company. In 2021, Mr Kantipudi spearheaded GVK BIO’s brand transformation into Aragen Life Sciences.
Since 2007, Mr Kantipudi has steered the company into becoming a leading R&D and manufacturing solutions provider to the global life science industry. He drove the acquisition of a biologics service provider in the US in 2014 (Aragen Bioscience) making GVK BIO (now known as Aragen) one of the first companies out of India to offer small and large molecule solutions.
Mr. Kantipudi has also been keenly involved in shaping company culture. Aragen was declared a Great Place to Work in 2020 and recertified in 2021, a first for a biopharmaceutical services company in India.
Prior to joining Aragen, Mr Kantipudi spent 16 years in the technology industry, holding various leadership and global positions in Asia and USA for Intel Corporation. He served as the Head of Intel India, the CIO of Intel Asia, and was responsible for the software in Intel’s WI-FI product line, Centrino.
D S Brar is a life sciences industry veteran, with a career spanning over four decades. Prior to joining Aragen (formerly known as GVK BIO) as Promoter-Chairman,...
Sanjay Reddy is the Founder-Vice Chairman of Aragen (formerly known as GVK BIO), and a successful entrepreneur with interests in energy, airports, transportation,...
Sej Brar is a Partner with L.E.K. Consulting’s global healthcare practice. He has over fifteen years of experience in advising leading global biopharma...
Indira Reddy entered into business in 1986, and has since built a long and successful career as Managing Director and Director of several companies. In...
As a Promoter-Director at Aragen, Keshav Reddy leads board-mandated strategic projects in finance, M&A, branding, structuring and vision planning for...
Robert Ruffolo is a distinguished scientist, globally recognized for his executive leadership in the pharmaceutical industry. He served as the President...
After 32 years of service, Gerhard Mayr retired as the Executive Vice President, Pharmaceutical Operations at Eli Lilly and Company, in March 2004. At...
Rajat Sood is a Managing Director in the Asset Management Division at Goldman Sachs, focused on corporate and growth equity investing in India. Mr. Sood...
Adam Dawson is a Managing Director in the Asset Management Division of Goldman Sachs, where he is responsible for equity investing in the healthcare and...
Ajay Srivastava, has worked with Citibank in the area of Transactional Services and Corporate and Investment Banking for many years. Thereafter, he founded...
Manni Kantipudi joined Aragen (formerly known as GVK BIO) in 2007 as President. He is presently CEO and member of the Board of Directors, responsible for...
